This study aimed to characterize the effects of semaglutide in the mouse nephrotoxic serum nephritis model, a nonobese and nondiabetic mouse model of CKD.<h4>Methods</h4>Mice were treated with semaglutide or the angiotensin-converting enzyme inhibitor enalapril for 14 days. Here, ACE is linked to nephritis.